Molded TPE Manifold Assemblies
Single-Use manifolds made from AdvantaFlex TPE tubing and molded fittings help eliminate risks such as leaks, entrapment and contamination that can occur with barbed fittings. Weldable and heat sealable.
Molded TPE Manifold Assemblies
Single-Use assemblies made from AdvantaFlex® biopharmaceutical grade TPE (thermoplastic elastomer) tubing and molded fittings eliminate processing risks such as leaks and contamination in biopharm and pharmaceutical applications. AdvantaFlex is sterile weldable and heat sealable, thus eliminating the need to splice silicone tubing sections into a process line, which can reduce operator errors. Tee, wye, cross, and reducer connections are available as well as hygienic union clamps and BioClosure® container closure systems. It meets USP Class VI, ISO and EP standards, provides excellent peristaltic pump life and does not contain animal-derived ingredients or silicone oils. AdvantaFlex assemblies are available with validated sterility assurance of 10-6 log reduction per ISO 11137 method VDmax and are made in USA.
AdvantaPure
145 James Way, Southampton, PA 18966 USA
+1-215-526-2151 • Fax +1-215-526-2167
[email protected]
General web address: http://www.advantapure.com
Product-specific address: http://www.advantapure.com/single-use-molded-manifolds.htm
Market Demands and Emerging Technologies Shape Outsourcing Models
June 5th 2025Trends in certain forms of drug delivery, as well as the emergence of artificial intelligence, are playing roles in evolving the nature of partnerships, but there are new types of partnerships gaining steam as well.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
The Role of On-Demand Manufacturing and Derisking in Accelerating Early Clinical Trial Success
June 4th 2025Small pharmaceutical companies are constantly seeking innovative solutions to streamline early clinical trials. Adaptive clinical trials offer important benefits to sponsors and patients, both from a commercial and ethical standpoint. These trials offer flexibility and efficiency, especially in the early stages, where trial protocols can be adjusted based on interim data, such as introducing new doses or modifying participant sample size. However, adjusting manufacturing demand during an adaptive trial can be complicated, and strict regulatory requirements present significant challenges. On-demand manufacturing provides a robust solution, allowing for real-time supply and demand adjustments and improved trial flexibility. This paper explores how on-demand manufacturing meets the operational needs of adaptive trials and aligns with regulatory expectations.
